Loading company…
Senticell develops red blood cell-based liquid biopsy and molecular diagnostic technologies.
Founded in 2022 in Pennsylvania, Senticell provides liquid biopsy and molecular diagnostics, including red blood cell-based technologies for analyzing nucleic acids and monitoring cancer. It was co-founded by Neha Shah and Nilam Mangalmurti. In September 2026, it raised USD 7 million in seed funding co-led by Capital Factory, Evoce Capital, Scalpel Ventures, and TheVentureCity, with individual investors also participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in